Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 1/20 | 0.35 |
| ▸ | NOTUM | Q6P988 | 3/20 | 0.33 |
| ▸ | TACR2 | P21452 | 2/20 | 0.33 |
| ▸ | PROKR2 | Q8NFJ6 | 2/20 | 0.32 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.32 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.32 |
| ▸ | ACACB | O00763 | 2/20 | 0.31 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.31 |
| ▸ | UGCG | Q16739 | 2/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | SSTR3 | P32745 | 2/20 | 0.31 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19904694 | 0.99 | HTR1A (0.35) | HTR1ANOTUMTACR2PROKR2PDCD1 | |
| SCHEMBL19904590 | 0.89 | KMT2A (0.36) | HTR1ANOTUMPROKR2PDCD1CD274 | |
| SCHEMBL19904455 | 0.89 | KMT2A (0.36) | HTR1ANOTUMPROKR2PDCD1CD274 | |
| SCHEMBL19904570 | 0.88 | NAMPT (0.33) | HTR1ANOTUMPDCD1CD274ACACB | |
| SCHEMBL19904686 | 0.88 | NAMPT (0.33) | HTR1ANOTUMPDCD1CD274ACACB | |
| SCHEMBL19904493 | 0.88 | KMT2A (0.38) | HTR1ATACR2PDCD1CD274ACACB | |
| SCHEMBL19904685 | 0.88 | KMT2A (0.38) | HTR1ATACR2PDCD1CD274ACACB | |
| SCHEMBL19904488 | 0.88 | KMT2A (0.38) | HTR1ANOTUMPROKR2PDCD1CD274 | |
| SCHEMBL19904593 | 0.87 | MCHR1 (0.36) | HTR1ACHRM2HDAC4 | |
| SCHEMBL19904324 | 0.87 | KDM4E (0.37) | HTR1ANOTUMACACBTRPV1UGCG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3063141-B1 | N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS | BIOMARIN PHARM INC (US) | 2018-02-28 | — | — | EP | disclosed |